nhic-20230630

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q/A

(Amendment No.1)

(Mark One)


x			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2023


¨			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______________ to

Commission file number: 001-39417

___________________________________

Evolv Technologies Holdings, Inc.

(Exact Name of Registrant as Specified in Its Charter)

___________________________________


Delaware			84-4473840
(State or Other Jurisdiction of Incorporation or Organization)			(I.R.S. Employer Identification No.)

500 Totten Pond Road, 4th Floor

Waltham, Massachusetts 02451

(Address of Principal Executive Offices)

(781) 374-8100

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading symbol

Name of Exchange on which registered

Class A common stock, par value $0.0001 per share

EVLV

The Nasdaq Stock Market

Warrants to purchase one share of Class A common stock

EVLVW

The Nasdaq Stock Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

As of August 9, 2023, there were 149,994,815 shares of Class A common stock, par value $0.0001 per share, outstanding.

Table of Contents

TABLE OF CONTENTS


		Page
Part I	Financial Information

Item 1.	Financial Statements

	Condensed Consolidated Balance Sheets (Unaudited , Restated )	F-1

	Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)	F-2

	Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited)	F-3

	Condensed Consolidated Statements of Cash Flows (Unaudited , Restated )	F-4

	Notes to Consolidated Financial Statements (Unaudited , Restated )	F-6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	16

Item 4.	Controls and Procedures	17

Part II	Other Information	19

Item 1.	Legal Proceedings	19

Item 1A.	Risk Factors	19

Item 2.	Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities	21

Item 3.	Defaults Upon Senior Securities	22

Item 4.	Mine Safety Disclosures	22

Item 5.	Other Information	22

Item 6.	Exhibits	23

Signatures

Table of Contents

EXPLANATORY NOTE

Evolv Technologies Holdings, Inc. ("Evolv," the "Company," "we," "our" or "us") is filing this Amendment No. 1 to its Quarterly Report on Form 10-Q/A (“Quarterly Report on Form 10-Q/A”) to amend and restate its unaudited condensed consolidated interim financial statements for the three and six months ended June 30, 2023 included in its Quarterly Report on Form 10-Q for the three months ended June 30, 2023, which was filed with the U.S. Securities and Exchange Commission (the "SEC") on August 10, 2023 (the "Original Report"). This Quarterly Report on Form 10-Q/A also amends certain other Items in the Original Report, as listed in "Items Amended in this Quarterly Report on Form 10-Q/A" below.

Restatement Background

As previously announced in our Current Report on Form 8-K filed with the SEC on October 25, 2023, the audit committee (the "Audit Committee") of the board of directors of the Company, in consultation with management, concluded that the Company's previously issued unaudited condensed consolidated interim financial statements for the three and six months ended June 30, 2023 included in the Original Report contained an error related to classification of certain marketable securities on the condensed consolidated balance sheet as of June 30, 2023, which also resulted in an error in the condensed consolidated statement of cash flows for the six months ended June 30, 2023. These errors are described in further detail below. As a result of the errors, the Audit Committee determined that the Company's consolidated financial statements included in the Original Report should no longer be relied upon. Similarly, any previously furnished or filed reports, related earnings releases, investor presentations or similar communications of the Company describing those financial statements and other information covering those periods should no longer be relied upon.

During the three months ended June 30, 2023, as part of its overall cash management strategy, the Company purchased zero coupon U.S. treasury bills with staggered maturities of between two months and six months. The Company classified all outstanding treasury bills as cash equivalents on its condensed consolidated balance sheet as of June 30, 2023. However, the treasury bills with maturities exceeding three months did not meet the definition of cash equivalents per Accounting Standards Codification 230 - Statement of Cash Flows, and should have been presented separately within current assets. The purchases of treasury bills with maturities greater than three months should have been presented as a cash outflow from investing activities within the condensed consolidated statement of cash flows for the six months ended June 30, 2023.

The errors did not impact total current assets, total assets, or total equity as of June 30, 2023. Further, the condensed consolidated statements of operations and comprehensive income for the three and six months ended June 30, 2023 and the condensed consolidated statements of stockholders' equity for the three and six months ended June 30, 2023 have not been adjusted as the impact of the errors on each statement was less than $0.1 million, which was deemed immaterial.

Additionally, in Note 3. Fair Value Measurements to the condensed consolidated financial statements included in the Original Report, the fair value of the treasury bills was incorrectly included in the caption "Money market funds," and should have been presented separately as a financial asset measured using Level 2 inputs under the fair value hierarchy. The restated financial statements also include certain required disclosures related to the investments in debt securities.

An explanation of the impact on the Company's financial statements is contained in Note 1. Nature of the Business and Basis of Presentation - Restatement to the accompanying financial statements.

Internal Control Considerations

Management has concluded that the errors are a result of the Company's previously disclosed material weaknesses in internal control over financial reporting related to the design and maintenance of effective controls over the period-end financial reporting process, including the classification of various accounts in the consolidated financial statements and the presentation and disclosure of items in the consolidated statements of cash flows. See Part I, Item 4. Controls and Procedures of this Quarterly Report on Form 10-Q/A.

Table of Contents

Items Amended in this Quarterly Report on Form 10-Q/A

This Quarterly Report on Form 10-Q/A sets forth our Original Report, as amended, in its entirety. Except as described below and set forth in this Quarterly Report on Form 10-Q/A, there were no changes to any other parts of the Original Report. Items included in the Original Report that are not amended by this Quarterly Report on Form 10-Q/A remain unchanged and in effect as of the date of the Original Report. Additionally, this Quarterly Report on Form 10-Q/A does not reflect events occurring after the date of the Original Report or modify or update those disclosures that may be affected by subsequent events, and no other changes are being made to any other disclosure contained in the Original Report.

The following items have been amended in this Quarterly Report on Form 10-Q/A, solely as a result of and to reflect the restatement:

•Part 1, Item 1. Financial Statements

•Part 1, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

•Part 1, Item 4. Controls and Procedures

•Part II, Item 1A. Risk Factors

•Part II, Item 6. Exhibits, to include, in accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended, currently dated certifications from our Principal Executive Officer and Principal Financial Officer, filed or furnished, as applicable, as Exhibits 31.1, 31.2, 32.1 and 32.2.

Table of Contents

FORWARD LOOKING STATEMENTS

This Quarterly Report on Form 10-Q/A contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this Quarterly Report on Form 10-Q/A, other than statements of historical fact, including, without limitation, statements regarding our results of operations and financial position, business strategy, plans and prospects, our relationship with significant manufacturers and suppliers, our ability to obtain new customers and retain existing customers, existing and prospective products, research and development costs, timing and likelihood of success, macroeconomic and market trends, and plans and objectives of management for future operations and results, are forward-looking statements. The words “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “forecasts,” “predicts,” “potential” or “continue” or the negative of these terms or other similar expressions are intended to identify forward-looking statements though not all forward-looking statement use these word or expressions.

The forward-looking statements in this Quarterly Report on Form 10-Q/A are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, without limitation risks relating to the restatement of our consolidated financial statements, expectations regarding the Company’s strategies and future financial performance, including its future business plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures; the Company’s history of losses and lack of profitability; the Company’s reliance on third party contract manufacturing and distribution, and a global supply chain; the rate of innovation required to maintain competitiveness in the markets in which the Company competes; the competitiveness of the market in which the Company competes; the failure of our products to detect threats could result in injury or loss of life, which could harm our brand, reputation, and results of operations; the loss of designation of our Evolv Express® system as a Qualified Anti-Terrorism Technology under the Homeland Security SAFETY Act; the ability for the Company to obtain, maintain, protect and enforce the Company’s intellectual property rights and use of “open source” software; the concentration of the Company’s revenues on a single solution; the Company’s ability to timely design, produce and launch its solutions, the Company’s ability to invest in growth initiatives and pursue acquisition opportunities; the limited liquidity and trading of the Company’s securities; risks related to existing and changing tax laws; geopolitical risk and changes in applicable laws or regulations; the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; operational risk; risks related to material weaknesses in our internal control over financial reporting and our remediation plans; risks related to increasing attention to and evolving expectations for, environmental, social, and governance initiatives, risk that the COVID-19 pandemic or a new pandemic may have an adverse effect on the Company’s business operations, as well as the Company’s financial condition and results of operations; the impact of fluctuating general economic and market conditions; the need for additional capital to support business growth, which might not be available on acceptable terms, if at all; and litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on resources; and other important factors discussed in Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as any such factors may be updated from time to time in its other filings with the SEC. Other than the sections we have amended in this Quarterly Report on Form 10-Q/A to reflect the restatement of our unaudited condensed consolidated interim financial statements for the three and six months ended June 30, 2023, forward-looking statements in this Quarterly Report on Form 10-Q/A are based upon information available to us as of the date of the Original Report, and while we believe such information forms a reasonable basis for such statements, it may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.

You should read this Quarterly Report on Form 10-Q/A and the documents that we reference in this Quarterly Report on Form 10-Q/A and have filed as exhibits to this Quarterly Report on Form 10-Q/A with the understanding that our actual future results, levels of activity, performance and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this Quarterly Report on

Table of Contents

Form 10-Q/A or to conform these statements to actual results or revised expectations, whether as a result of any new information, future events or otherwise.

GENERAL

We may announce material business and financial information to our investors using our investor relations website at https://ir.evolvtechnology.com/. We therefore encourage investors and others interested in Evolv to review the information that we make available on our website, in addition to following our filings with the SEC, webcasts, press releases and conference calls. Information contained on our website is not part of this Quarterly Report on Form 10-Q/A.

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share amounts)

(Unaudited)


	June 30, 2023 (Restated)		December 31, 2022
Assets
Current assets:
Cash and cash equivalents	$	125,890	$	229,783
Restricted cash	1,000		—
Marketable securities	29,647		—
Accounts receivable, net *	32,393		31,920
Inventory	5,032		10,257
Current portion of contract assets	4,732		2,852
Current portion of commission asset	3,648		3,384
Prepaid expenses and other current assets	13,808		14,388
Total current assets	216,150		292,584
Restricted cash, noncurrent	275		275
Contract assets, noncurrent	690		1,386
Commission asset, noncurrent	6,649		5,655
Property and equipment, net	81,085		44,707
Operating lease right-of-use assets	1,241		1,673
Other assets	1,878		1,835
Total assets	$	307,968	$	348,115

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	16,912	$	18,194
Accrued expenses and other current liabilities	10,821		11,545
Current portion of deferred revenue	39,366		18,273
Current portion of long-term debt	—		10,000
Current portion of operating lease liabilities	1,130		1,114
Total current liabilities	68,229		59,126
Deferred revenue, noncurrent	20,715		17,695
Long-term debt, noncurrent	—		19,683
Operating lease liabilities, noncurrent	363		892
Contingent earn-out liability	45,649		14,218
Contingently issuable common stock liability	9,229		3,392
Public warrant liability	19,625		6,124
Total liabilities	163,810		121,130
Commitments and contingencies (Note 14)

Stockholders’ equity:
Preferred stock, $0.0001 par value; 100,000,000 authorized at June 30, 2023 and December 31, 2022; no shares issued and outstanding at June 30, 2023 and December 31, 2022	—		—
Common stock, $0.0001 par value; 1,100,000,000 shares authorized at June 30, 2023 and December 31, 2022; 149,790,742 and 145,204,974 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively	15		15
Additional paid-in capital	431,759		419,190
Accumulated other comprehensive loss	(43)		(10)
Accumulated deficit	(287,573)		(192,210)
Stockholders’ equity	144,158		226,985
Total liabilities and stockholders’ equity	$	307,968	$	348,115

*Includes related party accounts receivable, net of $3.8 million and $14.6 million as of June 30, 2023 and December 31, 2022, respectively.

The accompanying notes are an integral part of these condensed consolidated financial statements.

F-1

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(In thousands, except share and per share amounts)

(Unaudited)


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Revenue:
Product revenue	$	7,243	$	4,146	$	15,997	$	9,340
Subscription revenue	7,964		4,006		14,430		7,010
Service revenue	4,618		918		7,979		1,430
Total revenue *	19,825		9,070		38,406		17,780
Cost of revenue:
Cost of product revenue	7,722		5,347		18,300		10,553
Cost of subscription revenue	3,406		1,981		5,757		3,523
Cost of service revenue	1,284		1,189		2,171		2,254
Total cost of revenue	12,412		8,517		26,228		16,330
Gross profit	7,413		553		12,178		1,450
Operating expenses:
Research and development	6,395		4,156		11,784		8,331
Sales and marketing	13,613		11,751		26,417		21,423
General and administrative	10,874		9,612		19,800		20,429
Loss from impairment of property and equipment	157		316		294		412
Total operating expenses	31,039		25,835		58,295		50,595
Loss from operations	(23,626)		(25,282)		(46,117)		(49,145)
Other income (expense), net:
Interest expense	—		(159)		(654)		(301)
Interest income	1,853		491		2,806		559
Other expense, net	(22)		—		(3)		—
Loss on extinguishment of debt	—		—		(626)		—

Change in fair value of contingent earn-out liability	(28,113)		(569)		(31,431)		2,509
Change in fair value of contingently issuable common stock liability	(5,095)		(24)		(5,837)		1,448
Change in fair value of public warrant liability	(11,751)		(143)		(13,501)		5,443

Total other income (expense), net	(43,128)		(404)		(49,246)		9,658










Net loss	$	(66,754)	$	(25,686)	$	(95,363)	$	(39,487)

Weighted average common shares outstanding – basic and diluted	148,882,160		143,552,032		147,664,534		143,220,268
Net loss per share - basic and diluted	$	(0.45)	$	(0.18)	$	(0.65)	$	(0.28)

Net loss	$	(66,754)	$	(25,686)	$	(95,363)	$	(39,487)
Other comprehensive loss
Cumulative translation adjustment	(17)		(10)		(33)		(10)
Total other comprehensive loss	(17)		(10)		(33)		(10)
Total comprehensive loss	$	(66,771)	$	(25,696)	$	(95,396)	$	(39,497)

*Includes related party revenue of $3.4 million and $2.2 million for the three months ended June 30, 2023 and 2022, respectively, and $7.0 million and $3.1 million for the six months ended June 30, 2023 and 2022, respectively.

The accompanying notes are an integral part of these condensed consolidated financial statements.

F-2

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

(In thousands, except share amounts)

(Unaudited)


	Common Stock			Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)		Accumulated Deficit		Total Stockholders’ Equity
	Shares	Amount
Balances at December 31, 2022	145,204,974	$	15	$	419,190	$	(10)	$	(192,210)	$	226,985
Issuance of common stock upon net exercise of stock options	100,587	—		33		—		—		33
Issuance of common stock upon vesting of restricted stock units	1,841,257	—		—		—		—		—
Issuance of common stock upon exercise of warrants	830,216	—		348		—		—		348
Stock-based compensation cost	—	—		5,101		—		—		5,101
Cumulative translation adjustment	—	—		—		(16)		—		(16)
Net loss	—	—		—		—		(28,609)		(28,609)
Balances at March 31, 2023	147,977,034	$	15	$	424,672	$	(26)	$	(220,819)	$	203,842
Issuance of common stock upon net exercise of stock options	775,193	—		310		—		—		310
Issuance of common stock upon vesting of restricted stock units	1,038,415	—		—		—		—		—
Issuance of common stock upon exercise of warrants	100	—		1		—		—		1
Stock-based compensation cost	—	—		6,776		—		—		6,776
Cumulative translation adjustment	—	—		—		(17)		—		(17)
Net loss	—	—		—		—		(66,754)		(66,754)
Balances at Balances at June 30, 2023	149,790,742	$	15	$	431,759	$	(43)	$	(287,573)	$	144,158

Balances at December 31, 2021	142,745,021	$	14	$	396,064	$	—	$	(105,804)	$	290,274
Issuance of common stock upon exercise of stock options	496,971	—		226		—		—		226
Issuance of common stock upon vesting of restricted stock units	80,044	—		—		—		—		—
Stock-based compensation cost	—	—		3,953		—		—		3,953
Net loss	—	—		—		—		(13,801)		(13,801)
Balances at March 31, 2022	143,322,036	$	14	$	400,243	$	—	$	(119,605)	$	280,652
Issuance of common stock upon net exercise of stock options	350,092	—		157		—		—		157
Issuance of common stock upon vesting of restricted stock units	157,867	—		—		—		—		—
Stock-based compensation cost	—	—		5,093		—		—		5,093
Cumulative translation adjustment	—	—		—		(10)		—		(10)
Net loss	—	—		—		—		(25,686)		(25,686)
Balances at June 30, 2022	143,829,995	$	14	$	405,493	$	(10)	$	(145,291)	$	260,206

The accompanying notes are an integral part of these condensed consolidated financial statements.

F-3

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)


	Six Months Ended June 30,
	2023 (Restated)		2022
Cash flows from operating activities:
Net loss	$	(95,363)	$	(39,487)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	4,087		2,350
Write-off of inventory and change in inventory reserve	337		425
Adjustment to property and equipment for sales type leases	—		(625)
Loss from impairment of property and equipment	294		412

Stock-based compensation	11,732		8,988
Non-cash interest expense	22		10
Accretion of discount on marketable securities	(242)		—
Non-cash lease expense	432		392
Change in allowance for expected credit losses	173		80
Loss on extinguishment of debt	626		—


Change in fair value of earn-out liability	31,431		(2,509)
Change in fair value of contingently issuable common stock	5,837		(1,448)
Change in fair value of public warrant liability	13,501		(5,443)
Changes in operating assets and liabilities
Accounts receivable	(646)		(5,786)
Inventory	5,080		(3,545)
Commission assets	(1,258)		(339)
Contract assets	(1,184)		(1,352)
Other assets	(43)		(756)
Prepaid expenses and other current assets	580		(9,707)
Accounts payable	(7,409)		2,147
Deferred revenue	24,113		6,031


Accrued expenses and other current liabilities	(342)		(1,876)
Operating lease liability	(513)		(457)
Net cash used in operating activities	(8,755)		(52,495)
Cash flows from investing activities:
Development of internal-use software	(1,599)		(1,301)
Purchases of property and equipment	(33,173)		(11,379)
Proceeds from sale of property and equipment	60		—
Purchases of marketable securities	(29,405)		—
Net cash used in investing activities	(64,117)		(12,680)
Cash flows from financing activities:
Proceeds from exercise of stock options and warrants	344		384




Proceeds from long-term debt	1,876		—
Repayment of principal on long-term debt	(31,876)		—
Payment of debt issuance costs and prepayment penalty	(332)		—
Net cash provided by (used in) financing activities	(29,988)		384
Effect of exchange rate changes on cash and cash equivalents	(33)		(10)
Net increase (decrease) in cash, cash equivalents and restricted cash	(102,893)		(64,801)
Cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period	230,058		308,167
Cash, cash equivalents and restricted cash at end of period	$	127,165	$	243,366

F-4

Table of Contents


	Six Months Ended June 30,
	2023 (Restated)		2022
Supplemental disclosure of cash flow information
Cash paid for interest	$	710	$	277
Supplemental disclosure of non-cash activities
Transfer of property and equipment to inventory	$	191	$	—
Capital expenditures incurred but not yet paid	13,572		4,256
Capitalization of stock compensation	218		57







Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	$	125,890	$	242,691
Restricted cash	1,000		400
Restricted cash, noncurrent	275		275
Total cash, cash equivalents and restricted cash shown in the statements of cash flows	$	127,165	$	243,366

The accompanying notes are an integral part of these condensed consolidated financial statements.

F-5

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. Nature of the Business and Basis of Presentation

Evolv Technologies Holdings, Inc. (the “Company”), a Delaware corporation, is a leader in AI-based weapons detection for security screening. The Company’s mission is to make the world a safer and more enjoyable place to live, work, learn, and play. The Company is democratizing security by making it seamless for gathering spaces to better address the chronic epidemic of escalating gun violence, mass shootings and terrorist attacks in a cost-effective manner while improving safety and the visitor experience. The Company is headquartered in Waltham, Massachusetts.

As used in this Quarterly Report on Form 10-Q/A, unless otherwise indicated or the context otherwise requires, references to “we,” “us,” “our,” the “Company” and “Evolv” refer to the consolidated operations of Evolv Technologies Holdings, Inc. and its wholly-owned subsidiaries, which include Evolv Technologies, Inc., Evolv Technologies UK Ltd. and Give Evolv LLC.

Basis of presentation

The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”).

Unaudited Interim Financial Information

The accompanying unaudited condensed consolidated financial statements as of June 30, 2023, and for the three and six months ended June 30, 2023 and 2022 have been prepared on the same basis as the audited annual consolidated financial statements as of December 31, 2022 and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of June 30, 2023 and the results of its operations for the three and six months ended June 30, 2023 and 2022 and cash flows for the six months ended June 30, 2023 and 2022. The results for the three and six months ended June 30, 2023 are not necessarily indicative of results to be expected for the year ending December 31, 2023, any other interim periods, or any future year or period.

Merger

On July 16, 2021, we consummated the business combination (the “Merger”), contemplated by the Agreement and Plan of Merger, dated March 5, 2021, with NHIC Sub Inc. (“Merger Sub”), a wholly-owned subsidiary of NewHold Investment Corp. (“NHIC”), a special purpose acquisition company, which is our legal predecessor, and Evolv Technologies, Inc. dba Evolv Technology, Inc. (“Legacy Evolv”), as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 by and among NHIC, Merger Sub and Legacy Evolv (the “Amendment” and as amended, the “Merger Agreement”). Pursuant to the Merger Agreement, Merger Sub was merged with and into Legacy Evolv, with Legacy Evolv surviving the Merger as a wholly-owned subsidiary of NHIC. Upon the closing of the Merger, NHIC changed its name to Evolv Technologies Holdings, Inc. Evolv Technologies Holdings, Inc. became the successor entity to NHIC pursuant to Rule 12g-3(a) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

Restatement

The Company is restating its previously issued condensed consolidated financial statements and related notes as of and for the three and six months ended June 30, 2023. The Company identified an error related to classification of certain marketable securities on the condensed consolidated balance sheet as of June 30, 2023, which also resulted in an error in the condensed consolidated statement of cash flows for the six months ended June 30, 2023.

F-6

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

A summary of the impact of the error on the condensed consolidated balance sheet as of June 30, 2023 is as follows (amounts in thousands):


	As Reported		Adjustment		As Restated
Current assets:
Cash and cash equivalents	$	155,537	$	(29,647)	$	125,890
Restricted cash	1,000		—		1,000
Marketable securities	—		29,647		29,647
Accounts receivable, net	32,393		—		32,393
Inventory	5,032		—		5,032
Current portion of contract assets	4,732		—		4,732
Current portion of commission asset	3,648		—		3,648
Prepaid expenses and other current assets	13,808		—		13,808
Total current assets	216,150		—		216,150

Total assets	$	307,968	$	—	$	307,968
Total liabilities	$	163,810	$	—	$	163,810
Stockholders’ equity	$	144,158	$	—	$	144,158
Total liabilities and stockholders’ equity	$	307,968	$	—	$	307,968

F-7

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

A summary of the impact of the error on the condensed consolidated statement of cash flows for the six months ended June 30, 2023 is as follows (amounts in thousands):


	As Reported		Adjustment		As Restated
Cash flows from operating activities:
Net loss	$	(95,363)	$	—	$	(95,363)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	4,087		—		4,087
Write-off of inventory and change in inventory reserve	337		—		337
Loss from impairment of property and equipment	294		—		294
Stock-based compensation	11,732		—		11,732
Non-cash interest expense	22		—		22
Accretion of discount on marketable securities	—		(242)		(242)
Non-cash lease expense	432		—		432
Change in allowance for expected credit losses	173		—		173
Loss on extinguishment of debt	626		—		626
Change in fair value of earn-out liability	31,431		—		31,431
Change in fair value of contingently issuable common stock	5,837		—		5,837
Change in fair value of public warrant liability	13,501		—		13,501
Changes in operating assets and liabilities			—		—
Accounts receivable	(646)		—		(646)
Inventory	5,080		—		5,080
Commission assets	(1,258)		—		(1,258)
Contract assets	(1,184)		—		(1,184)
Other assets	(43)		—		(43)
Prepaid expenses and other current assets	580		—		580
Accounts payable	(7,409)		—		(7,409)
Deferred revenue	24,113		—		24,113
Accrued expenses and other current liabilities	(342)		—		(342)
Operating lease liability	(513)		—		(513)
Net cash used in operating activities	(8,513)		(242)		(8,755)
Cash flows from investing activities:
Development of internal-use software	(1,599)		—		(1,599)
Purchases of property and equipment	(33,173)		—		(33,173)
Proceeds from sale of property and equipment	60		—		60
Purchases of marketable securities	—		(29,405)		(29,405)
Net cash used in investing activities	(34,712)		(29,405)		(64,117)

Net cash provided by (used in) financing activities	$	(29,988)	$	—	$	(29,988)
Effect of exchange rate changes on cash and cash equivalents	$	(33)	$	—	$	(33)
Net increase (decrease) in cash, cash equivalents and restricted cash	$	(73,246)	$	(29,647)	$	(102,893)
Cash, cash equivalents and restricted cash at end of period	$	156,812	$	(29,647)	$	127,165

Additionally, Note 4. Fair Value Measurements (As Restated), has been restated to present the treasury bills separately as a financial asset measured using Level 2 inputs under the fair value hierarchy. The previously issued condensed consolidated financial statements incorrectly included the treasury bills in the caption "Money market funds," which are measured using Level 1 inputs under the fair value hierarchy. The restated financial statements also include certain required disclosures related to these investments in debt securities. These are included in Note 3. Marketable Securities (As Restated).

F-8

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

2. Summary of Significant Accounting Policies

Significant Accounting Policies

The significant accounting policies and estimates used in preparation of the unaudited condensed consolidated financial statements are described in the Company’s audited consolidated financial statements as of and for the year ended December 31, 2022, and the notes thereto, which are included in our Annual Report on Form 10-K for the year ended December 31, 2022. There have been no material changes to the Company’s significant accounting policies during the six months ended June 30, 2023.

Recently Adopted Accounting Pronouncements

The Company qualifies as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 and has elected not to “opt out” to the extended transition related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, the Company will adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and will do so until such time that the Company either (1) irrevocably elects to “opt out” of such extended transition period or (2) no longer qualifies as an emerging growth company. The Company may choose to early adopt any new or revised accounting standards whenever such early adoption is permitted for nonpublic companies. Based on our public float as of June 30, 2023, we expect to become a large accelerated filer and lose emerging growth company status as of December 31, 2023. As of December 31, 2023, we will be required to adopt new or revised accounting standards when they are applicable to public companies that are not emerging growth companies. Based on our public float as of June 30, 2023, we also expect to transition out of smaller reporting company status as of December 31, 2023 and will no longer be able to rely on the scaled disclosure requirements allowed for smaller reporting companies.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326) (“ASU 2016-13”). The new standard adjusts the accounting for assets held at amortized cost basis, including marketable securities accounted for as available for sale, and trade receivables. The standard eliminates the probable initial recognition threshold and requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For public entities except smaller reporting companies, the guidance is effective for annual reporting periods beginning after December 15, 2019 and for interim periods within those fiscal years. In November 2019, the FASB issued ASU No. 2019-10, which deferred the effective date for non-public entities and smaller reporting companies to annual reporting periods beginning after December 15, 2022, including interim periods within those fiscal years. Early application is allowed. The Company adopted this guidance effective January 1, 2023, and the adoption of this guidance did not have a material impact on its consolidated financial statements and related disclosures.

In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which amends ASC 805 to add contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and to require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. The amendments in ASU 2021-08 are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption of the amendments is permitted, including adoption in an interim period. The Company adopted this guidance effective January 1, 2023, and the adoption of this guidance did not have an impact on its consolidated financial statements and related disclosures.

3. Marketable Securities (As Restated)

Marketable securities as of June 30, 2023 consisted of the following:

F-9

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


	June 30, 2023
	Amortized Cost		Unrealized Gain/(Loss)		Fair Value
U.S. Treasury bills	$	29,647	$	—	$	29,647
Total marketable securities	$	29,647	$	—	$	29,647

Marketable securities are reported at fair value and, at June 30, 2023, are comprised solely of zero coupon U.S. treasury bills with maturities of less than one year that are classified as available-for-sale debt securities. The Company did not record any unrealized gains or losses on available-for-sale securities for the three or six months ended June 30, 2023. The accretion of discounts on marketable securities is included in interest income on the condensed consolidated statements of operations and comprehensive income. The Company did not have any marketable securities as of December 31, 2022.

The Company considers an available-for-sale debt security to be impaired if the fair value of the investment is less than its amortized cost basis. The entire difference between the amortized cost basis and the fair value of the Company’s available-for-sale debt securities is recognized on the condensed consolidated statements of operations as an impairment if, (i) the fair value of the security is below its amortized cost and (ii) the Company intends to sell or is more likely than not required to sell the security before recovery of its amortized cost basis. If neither criterion is met, the Company evaluates whether the decline in fair value is due to credit losses or other factors. In making this assessment, the Company considers the changes to the rating of the security by third-party rating agencies, and adverse conditions specific to the security, among other factors. If the Company’s assessment indicates that a credit loss exists, the credit loss is measured based on the Company’s best estimate of the cash flows expected to be collected. When developing its estimate of cash flows expected to be collected, the Company considers all available information relevant to the collectability of the security, including past events, current conditions, and reasonable and supportable forecasts.

4. Fair Value Measurements (As Restated)

The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values (in thousands):


	Fair Value Measurements at June 30, 2023
	Level 1		Level 2		Level 3		Total
Assets:
Money market funds	$	101,998	$	—	$	—	$	101,998
U.S. Treasury bills	—		39,614		—		39,614
	$	101,998	$	39,614	$	—	$	141,612
Liabilities:
Contingent earn-out liability	$	—	$	—	$	45,649	$	45,649
Contingently issuable common stock liability	—		—		9,229		9,229
Public Warrant liability	19,625		—		—		19,625
	$	19,625	$	—	$	54,878	$	74,503

F-10

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


	Fair Value Measurements as of December 31, 2022
	Level 1		Level 2		Level 3		Total
Assets:
Money market funds	$	149,971	$	—	$	—	$	149,971
	$	149,971	$	—	$	—	$	149,971
Liabilities:
Contingent earn-out liability	$	—	$	—	$	14,218	$	14,218
Contingently issuable common stock liability	—		—		3,392		3,392
Public Warrant liability	6,124		—		—		6,124
	$	6,124	$	—	$	17,610	$	23,734

Money market funds are included in cash and cash equivalents on the condensed consolidated balance sheets. U.S. Treasury bills with maturities less than 3 months, which totaled $10.0 million as of June 30, 2023, are included in cash and cash equivalents, while treasury bills with maturities greater than 3 months, which totaled $29.6 million as of June 30, 2023, are reflected as marketable securities. The fair value of the treasury bills, which are classified as Level 2 securities, is calculated by a third-party pricing service and is based on estimates obtained from various sources.

The Company may also value its non-financial assets and liabilities, including items such as inventories and property and equipment, at fair value on a non-recurring basis if it is determined that impairment has occurred. Such fair value measurements use significant unobservable inputs and are classified as Level 3.

During each of the three and six months ended June 30, 2023 and 2022, there were no transfers between Level 1, Level 2 and Level 3.

Valuation of Contingent Earn-out

Pursuant to the Merger Agreement, the Legacy Evolv stockholders, immediately prior to the Merger, were entitled to receive additional shares of the Company’s common stock upon the Company achieving certain milestones as described in Note 2 of our consolidated financial statements of our Annual Report on Form 10-K for the year ended December 31, 2022. The Company’s contingent earn-out shares were recorded at fair value as contingent earn-out liability upon the closing of the Merger and are remeasured each reporting period. As of June 30, 2023, no milestones have been achieved.

The fair value of the contingent earn-out is calculated using a Monte Carlo analysis in order to simulate the future path of the Company’s stock price over the earn-out period. The carrying amount of the liability may fluctuate significantly and actual amounts paid may be materially different from the liability’s estimated value. The significant assumptions used in the Monte Carlo model as of June 30, 2023 were as follows: 85% expected stock price volatility, a risk-free rate of return of 4.6%, a 25% likelihood of change in control and a remaining term of 2.7 years.

The following table provides a rollforward of the contingent earn-out liability (in thousands):


Balance at December 31, 2022	$	14,218
Change in fair value	31,431
Balance at June 30, 2023	$	45,649

Valuation of Contingently Issuable Common Stock

Prior to the Merger, certain NHIC stockholders owned 4,312,500 shares of NHIC Class B common stock (the "Founder Shares"). Upon the closing of the Merger, NHIC Class A and Class B common stock became the Company's common stock. 1,897,500 Founder Shares vested at the closing of the Merger, 517,500 Founder Shares were transferred back to NHIC and then contributed to Give Evolv LLC, and the remaining 1,897,500 outstanding Founder Shares are contingently issuable and shall vest upon the Company achieving certain milestones as described in Note 2 of our

F-11

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

consolidated financial statements of our Annual Report on Form 10-K for the year ended December 31, 2022. The Company’s contingently issuable common shares were recorded at fair value on the closing of the Merger and are remeasured each reporting period. As of June 30, 2023, no milestones have been achieved.

The fair value of the contingently issued common shares is determined using a Monte Carlo analysis in order to simulate the future path of the Company’s stock price over the vesting period. The carrying amount of the liability may fluctuate significantly and actual amounts paid may be materially different from the liability’s estimated value. The significant assumptions used in the Monte Carlo model as of June 30, 2023 were as follows: 85% expected stock price volatility, a risk-free rate of return of 4.5%, a 25% likelihood of change in control and a remaining term of 3.1 years.

The following table provides a rollforward of the contingently issuable common shares (in thousands):


Balance at December 31, 2022	$	3,392
Change in fair value	5,837
Balance at June 30, 2023	$	9,229

Valuation of Public Warrant Liability

In connection with the closing of the Merger, the Company assumed warrants (the "Public Warrants") to purchase 14,325,000 shares of common stock at an exercise price of $11.50. The Public Warrants are immediately exercisable and expire in July 2026. The Public Warrants are classified as a liability and are subsequently remeasured to fair value at each reporting date based on the closing price as reported by Nasdaq on the last date of the reporting period. As of June 30, 2023, 14,324,893 Public Warrants are outstanding.

The following table provides a rollforward of the public warrant liability (in thousands):


Balance at December 31, 2022	$	6,124
Change in fair value	13,501
Balance at June 30, 2023	$	19,625

5. Revenue Recognition

The Company recognizes revenue in accordance with Accounting Standards Codification 606 – Revenue from Contracts with Customers (“ASC 606”). Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. In order to achieve this core principle, the Company applies the following five steps when recording revenue: (1) identify the contract, or contracts, with the customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when, or as, performance obligations are satisfied.

The Company derives revenue from (1) subscription arrangements generally accounted for as operating leases under ASC 842 and (2) from the sale of products, inclusive of SaaS and maintenance, (3) professional services, and (4) license fees related to a distribution and license agreement with the Company's primary contract manufacturer. The Company’s arrangements are generally noncancelable and nonrefundable after shipment to the customer. Revenue is recognized net of sales tax.

Remaining Performance Obligations

The following table includes estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied (or partially satisfied) as of June 30, 2023

F-12

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)


	Less than 1 year		Greater than 1 year		Total
Product revenue	$	3,050	$	—	$	3,050
Subscription revenue	42,140		92,099		134,239
Service revenue	17,883		43,124		61,007
Total revenue	$	63,073	$	135,223	$	198,296

The amount of minimum future leases is based on expected income recognition. As of June 30, 2023, future minimum payments on noncancelable leases are as follows (in thousands):


Year Ending December 31:
2023 (six months remaining)	$	21,253
2024	41,340
2025	37,364
2026	26,748
2027	7,511
Thereafter	23
	$	134,239

Contract Balances from Contracts with Customers

Contract assets arise from unbilled amounts in customer arrangements when revenue recognized exceeds the amount billed to the customer and the Company’s right to payment is conditional and not only subject to the passage of time. As of June 30, 2023 and December 31, 2022, the Company had $4.7 million and $2.9 million in current portion of contract assets and $0.7 million and $1.4 million in contract assets, noncurrent on the condensed consolidated balance sheets, respectively.

Contract liabilities represent the Company’s obligation to transfer goods or services to a customer for which it has received consideration (or the amount is due) from the customer. The Company has a contract liability related to service revenue, which consists of amounts that have been invoiced but that have not been recognized as revenue. Amounts expected to be recognized as revenue within 12 months of the balance sheet date are classified as current deferred revenue and amounts expected to be recognized as revenue beyond 12 months of the balance sheet date are classified as deferred revenue, noncurrent. The Company recognized revenue of $5.3 million and $12.1 million during the three and six months ended June 30, 2023 that was included in the December 31, 2022 deferred revenue balance. The Company recognized revenue of $2.2 million and $4.7 million during the three and six months ended June 30, 2022 that was included in the December 31, 2021 deferred revenue balance.

F-13

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

The following table provides a rollforward of deferred revenue (in thousands):


Balance at December 31, 2022	$	35,968
Revenue recognized in relation to the beginning of the year contract liability balance	(12,140)
Revenue deferred	36,253
Balance at June 30, 2023	$	60,081

The following table presents the Company’s components of lease revenue (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Revenue from sales-type leases	$	—	$	—	$	—	$	1,106
Interest income on lease receivables	51		61		104		110
Lease income - operating leases	7,964		4,006		14,430		7,010
Total lease revenue	$	8,015	$	4,067	$	14,534	$	8,226

The revenue from sales-type leases is related to the Evolv Express units where the lease term is for the major part of the economic life of the underlying equipment and is classified as product revenue in the condensed consolidated statements of operations and comprehensive loss. The interest income on lease receivables is classified under interest income in the condensed consolidated statements of operations and comprehensive loss. The lease income from operating leases is related to the leased equipment under subscription arrangements and is classified as subscription revenue in the condensed consolidated statements of operations and comprehensive loss. Revenue related to leases entered into with related parties were less than $0.1 million and $0.2 million during the three and six months ended June 30, 2023, respectively. Revenue related to leases entered into with related parties were $0.2 million and $0.3 million during the three and six months ended June 30, 2022, respectively.

Disaggregated Revenue

The following table presents the Company’s revenue by revenue stream (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Product revenue	$	7,243	$	4,146	$	15,997	$	9,340
Leased equipment	7,964		4,006		14,430		7,010
SaaS, maintenance, and other revenue	4,121		729		6,899		1,097
Professional services	497		189		1,080		333
Total revenue	$	19,825	$	9,070	$	38,406	$	17,780

Commissions

The Company incurs and pays commissions on product sales. The Company applies the practical expedient for contracts less than one year to expense the commission costs in the period in which they were incurred. Commissions on product sales and services are expensed in the period in which the related revenue is recognized. Commissions on subscription arrangements and maintenance are expensed ratably over the life of the contract. The Company had a deferred asset related to commissions of $10.3 million and $9.0 million as of June 30, 2023 and December 31, 2022, respectively. During the three months ended June 30, 2023 and 2022, the Company recognized commission expense of $1.5 million and $0.9 million, respectively. During the six months ended June 30, 2023 and 2022, the Company recognized commission expense of $3.1 million and $1.2 million, respectively.

F-14

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

6. Accounts Receivable

Allowance for Expected Credit Losses

Changes in the allowance for expected credit losses were as follows (in thousands):


	Allowance for Doubtful Accounts
Balance at December 31, 2022	$	(200)
Provisions	(182)
Write-offs, net of recoveries	9
Balance at June 30, 2023	$	(373)

7. Inventory

Inventory consisted of the following (in thousands):


	June 30, 2023		December 31, 2022
Raw materials	$	3,250	$	2,334
Finished goods	1,782		7,923
Total	$	5,032	$	10,257

8. Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):


	June 30, 2023		December 31, 2022
Computers and telecom equipment	$	1,001	$	599
Lab equipment	951		871
Furniture and fixtures	111		111
Leasehold improvements	542		542
Leased equipment	57,143		35,983
Capitalized software	6,002		4,150
Sales demo equipment	2,689		2,340
Equipment held for lease1	24,183		7,826
Construction in progress	156		71
	92,778		52,493
Less: Accumulated depreciation and amortization	(11,693)		(7,786)
	$	81,085	$	44,707

1 Represents equipment that has not yet been deployed to a customer and, accordingly, is not being depreciated.

As of June 30, 2023 and December 31, 2022, the net book value of capitalized software was $4.9 million and $3.5 million, respectively. These amounts include $0.4 million and $0.2 million of capitalized stock compensation costs, respectively. Depreciation and amortization expense related to property and equipment was $2.3 million and $1.3 million for the three months ended June 30, 2023 and 2022, and $4.1 million and $2.4 million for the six months ended June 30, 2023 and 2022, respectively.

F-15

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Leased equipment and the related accumulated depreciation were as follows:


	June 30, 2023		December 31, 2022
Leased equipment	$	57,143	$	35,983
Accumulated depreciation	(8,805)		(5,802)
Leased equipment, net	$	48,338	$	30,181

Depreciation expense related to leased units was $1.8 million and $1.0 million during the three months ended June 30, 2023 and 2022, and $3.2 million and $1.9 million for the six months ended June 30, 2023 and 2022, respectively. Depreciable lives are generally 7 years, consistent with the Company’s planned and historical usage of the equipment subject to operating leases.

9. Long-term Debt

The components of the Company’s long-term debt consisted of the following (in thousands):


	June 30, 2023		December 31, 2022
Term loans payable	$	—	$	30,000
Less: Unamortized discount	—		(317)
	—		29,683
Less: Current portion of long-term debt	—		10,000
Long-term debt, net of discount	$	—	$	19,683

Silicon Valley Bank Term Loan Agreement

In December 2022, the Company entered into a loan and security agreement (the "2022 SVB Credit Agreement") with Silicon Valley Bank ("SVB") in order to finance purchases of hardware to be leased to customers. The 2022 SVB Credit Agreement provided for an initial term loan advance of $30.0 million, which was approximately equivalent to the value of all hardware purchases made to support leasing transactions with the Company's customers through December 21, 2022 (the "SVB Closing Date"), with the opportunity to obtain, within 18 months after the SVB Closing Date, additional term loan advances, subject to the satisfaction of certain conditions, in an aggregate principal amount equal to $20.0 million (subject to an increase of an additional $25.0 million upon the satisfaction of certain conditions and approval from SVB). The interest rate applicable to the SVB Term Loans was the greater of (a) the Wall Street Journal Prime Rate plus 1.0% or (b) 7.25% per annum. Interest and principal under the SVB Credit Agreement was payable monthly.

On March 10, 2023, SVB was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Corporation ("FDIC") as receiver. The FDIC created a successor bridge bank, Silicon Valley Bridge Bank, N.A. ("SVBB"), and all deposits of SVB were transferred to SVBB under a systemic risk exception approved by the Federal Reserve, the U.S. Treasury Department, and the FDIC. On March 12, 2023, the Federal Reserve, the U.S. Treasury Department, and the FDIC announced in a joint statement that all SVB deposits, including both insured and uninsured amounts, would be available in full to account holders. SVB was acquired by First Citizens Bank on March 27, 2023.

In light of the foregoing, on March 28, 2023, upon the recommendation of the Company’s newly-formed Investment Committee of the Board of Directors, the Company (i) gave notice of its desire and intent to terminate the commitments under the 2022 SVB Credit Agreement and (ii) transferred its excess cash out of First Citizens Bank (the “Transfer”). The Transfer resulted in an event of default under the 2022 SVB Credit Agreement. Upon the occurrence of such event of default, First Citizens Bank could have, but was not required to, declare all obligations under the 2022 SVB

F-16

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Credit Agreement immediately due and payable. First Citizens Bank did not make such declaration following such event of default.

On March 31, 2023, the Company fully repaid all borrowings and accrued interest under the 2022 SVB Credit Agreement and terminated the 2022 SVB Credit Agreement. In accordance with the terms of the 2022 SVB Credit Agreement, the Company was required to pay a prepayment premium equal to 1.0% of the principal balance on the date of repayment. The Company incurred a loss on debt extinguishment of $0.6 million, consisting of the prepayment penalty of $0.3 million and the write-off of $0.3 million of unamortized debt issuance costs.

10. Stock-Based Compensation

Stock Options

The following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted during the six months ended June 30, 2023 and 2022:


	Six Months Ended June 30,
	2023		2022
Risk-free interest rate	4.2	%	1.6	%
Expected term (in years)	6.1		6.1
Expected volatility	87.5	%	75.0	%
Expected dividend yield	0.0	%	0.0	%

The following table summarizes the Company’s stock option activity since December 31, 2022 (in thousands, except for share and per share data):


	Number of Shares	Weighted Average Exercise Price

Outstanding as of December 31, 2022	20,396,824	$	0.73
Granted	2,840,421	3.12
Exercised	(875,780)	0.39
Forfeited	(20,468)	0.42
Outstanding as of June 30, 2023	22,340,997	1.05

Restricted Stock Units

The following table summarizes the Company's restricted stock units activity since December 31, 2022:


	Number of Shares	Grant Date Fair Value

Outstanding as of December 31, 2022	7,501,945	$	3.54
Granted	7,742,983	3.25
Vested	(2,447,672)	3.40
Forfeited	(345,516)	3.75
Outstanding as of June 30, 2023	12,451,740	$	3.38

F-17

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Performance Stock Units

The following table summarizes the Company's performance stock units activity since December 31, 2022:


	Number of Shares	Grant Date Fair Value

Outstanding as of December 31, 2022	864,000	$	2.65
Granted	—	—
Vested	(432,000)	2.65
Forfeited	(25,000)	2.65
Outstanding as of June 30, 2023	407,000	$	2.65

Finback Common Stock Warrants

In January 2021, the Company granted warrants (the "Finback Common Stock Warrants") to purchase 2,552,913 shares of the Company's Class A common stock at an exercise price of $0.42 per share to Finback Evolv OBH, LLC ("Finback"), a consulting group affiliated with one of the Company's stockholders. The Finback Common Stock Warrants vest upon meeting certain sales criteria as defined in a business development agreement (the "Finback BDA"), which has a term of 3 years. The Finback BDA expired on January 1, 2023 but includes a 1-year "tail period" expiring on January 1, 2024. During the tail period, Finback Common Stock Warrants will continue to vest related to any sale consummated by the Company for which it is determined Finback provided services prior to January 1, 2023 in furtherance of the sale. The Finback Common Stock Warrants expire in January 2031. The Finback Common Stock Warrants are accounted for under ASC 718 Compensation – Stock Compensation as the warrants vest upon certain performance conditions being met.

During the six months ended June 30, 2023, 830,216 Finback Common Stock Warrants were exercised. As of June 30, 2023, 175,599 Finback Common Stock Warrants were exercisable at a total aggregate intrinsic value of $1.0 million, and 1,415,385 Finback Common Stock Warrants are unvested and have a total unrecognized grant date fair value of $10.8 million. During the three months ended June 30, 2023 and 2022, the Company recorded $0.8 million and $0.6 million, respectively, of stock-based compensation expense within sales and marketing expense related to the Finback Common Stock Warrants. During the six months ended June 30, 2023 and 2022, the Company recorded $1.4 million and $0.8 million, respectively, of stock-based compensation expense within sales and marketing expense related to the Finback Common Stock Warrants.

Stock-Based Compensation

Stock-based compensation expense was classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Cost of revenue	$	184	$	280	$	329	$	388
Research and development	1,238		931		2,075		1,479
Sales and marketing	2,508		2,344		4,506		3,828
General and administrative	2,759		1,506		4,822		3,293
Total stock-based compensation expense	$	6,689	$	5,061	$	11,732	$	8,988

F-18

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

11. Income Taxes

There is no provision for income taxes for the three and six months ended June 30, 2023 and 2022 because the Company has historically incurred net operating losses and maintains a full valuation allowance against its deferred tax assets.

The Company’s tax provision and the resulting effective tax rate for interim periods is determined based upon its estimated annual effective tax rate (“AETR”), adjusted for the effect of discrete items arising in that quarter. The impact of such inclusions could result in a higher or lower effective tax rate during a particular quarter, based upon the mix and timing of actual earnings or losses versus annual projections. In each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual tax rate changes, a cumulative adjustment is made in that quarter.

12. Net Loss per Share

Basic and diluted net loss per share attributable to common stockholders was calculated as follows (in thousands, except share and per share amounts):


	Three Months Ended June 30,						Six Months Ended June 30,
	2023		2022				2023		2022
Numerator:







Net income (loss) attributable to common stockholders – basic and diluted	$	(66,754)	$	(25,686)	$	—	$	(95,363)	$	(39,487)

Denominator:











Weighted average common shares outstanding - basic and diluted	148,882,160		143,552,032				147,664,534		143,220,268
Net loss per share attributable to common stockholders – basic and diluted	$	(0.45)	$	(0.18)			$	(0.65)	$	(0.28)

The following potentially dilutive outstanding securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period:


	Three Months Ended June 30,		Six Months Ended June 30,
	2023	2022	2023	2022
Options issued and outstanding	22,340,997	21,567,577	22,340,997	21,567,577
Public Warrants to purchase common stock	14,324,893	14,324,994	14,324,893	14,324,994



Warrants to purchase common stock (Finback)**	1,590,984	2,421,200	1,590,984	2,421,200
Unvested restricted stock units	12,451,740	7,446,143	12,451,740	7,446,143
Unvested performance stock units	407,000	914,000	407,000	914,000
Earn-out shares*	15,000,000	15,000,000	15,000,000	15,000,000
Contingently issuable common stock*	1,897,500	1,897,500	1,897,500	1,897,500

	68,013,114	63,571,414	68,013,114	63,571,414

*Issuance of Earn-out shares and Contingently issuable common stock is contingent upon the satisfaction of certain conditions, which were not satisfied by the end of the period

**Includes 175,599 vested warrants and 1,415,385 unvested warrants as of June 30, 2023

F-19

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

13. Related Party Transactions

Business Development Agreement with Finback

In January 2021, the Company granted the Finback Common Stock Warrants subject to the terms of the Finback BDA, as discussed in Note 10.

In connection with the Merger and pursuant to the Merger Agreement, in addition to earn-out shares allocated to Finback based on its common stock ownership percentage as of the Merger date, Finback is entitled to receive a proportional share of earn-out shares based upon its remaining unvested warrants as of the Merger Date.

Original Equipment Manufacturer Partnership Agreement with Motorola

In December 2020, the Company entered into an original equipment manufacturer partnership agreement with Motorola Solutions, Inc. ("Motorola"), an investor in the Company. The partnership agreement has since been amended and restated. Motorola sells Motorola-branded premium products based on the Evolv Express platform through their worldwide network of over 2,000 resellers and integration partners, and has integrated the Evolv Express platform with Motorola products. During the three months ended June 30, 2023 and 2022, revenue from Motorola's distributor services was $2.9 million and $1.9 million, respectively. During the six months ended June 30, 2023 and 2022, revenue from Motorola's distributor services was $6.2 million and $2.8 million, respectively. As of June 30, 2023 and December 31, 2022, accounts receivable related to Motorola’s distributor services was $3.0 million and $12.5 million, respectively.

Reseller Agreement with Stanley Black & Decker

In June 2020, the Company entered into a reseller agreement with Stanley Black & Decker, an investor in the Company. Stanley Black & Decker's electronic security business was acquired by Securitas AB ("Securitas") in 2023. Securitas, directly or through its affiliates, resells the Company's products. During the three months ended June 30, 2023 and 2022, revenue from Securitas' reseller services was $0.5 million and $0.3 million, respectively. During the six months ended June 30, 2023 and 2022, revenue from Securitas' reseller services was $0.9 million and $0.3 million, respectively. As of June 30, 2023 and December 31, 2022, accounts receivable related to Securitas' reseller services was $0.9 million and $2.2 million, respectively.

14. Commitments and Contingencies

Indemnification Agreements

In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with members of its Board of Directors and certain of its executive officers and employees that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their role, status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. To date, the Company has not incurred any material costs as a result of such indemnifications. The Company is not currently aware of any indemnification claims and has not accrued any liabilities related to such obligations in its condensed consolidated financial statements as of June 30, 2023 or December 31, 2022.

Legal Proceedings and Other Matters

The Company is not a party to any litigation of a material nature and does not have contingency reserves established for any litigation liabilities. At each reporting date, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company expenses the costs related to such legal proceedings as incurred.

F-20

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

In the ordinary course of business, the Company is subject to regulatory and governmental examinations, information gathering requests, inquiries and investigations. We do not expect such examinations, requests, inquiries or investigations to have a material effect on our results of operations, financial condition or liquidity, either individually or in the aggregate.

F-21

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion and analysis of our financial condition and results of operations together with our condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q/A and our audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2022 (the "2022 Form 10-K"). This discussion contains forward-looking statements based upon current plans, expectations and beliefs involving risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under “Risk Factors” section of our 2022 Form 10-K and in other parts of this Quarterly Report on Form 10-Q/A.

On July 16, 2021, we consummated the business combination (the “Merger”), contemplated by the Agreement and Plan of Merger, dated March 5, 2021, with NHIC Sub Inc. (“Merger Sub”), a wholly-owned subsidiary of NewHold Investment Corp. (“NHIC”), a special purpose acquisition company, which is our legal predecessor, and Evolv Technologies, Inc. dba Evolv Technology, Inc. (“Legacy Evolv”), as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 by and among NHIC, Merger Sub and Legacy Evolv (the “Amendment” and as amended, the “Merger Agreement”). Pursuant to the Merger Agreement, Merger Sub was merged with and into Legacy Evolv, with Legacy Evolv surviving the merger as a wholly-owned subsidiary of NHIC. Upon the closing of the Merger, NHIC changed its name to Evolv Technologies Holdings, Inc. Evolv Technologies Holdings, Inc. became the successor entity to NHIC pursuant to Rule 12g-3(a) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

As used in this Quarterly Report on Form 10-Q/A, unless otherwise indicated or the context otherwise requires, references to “we,” “us,” “our,” the “Company” and “Evolv” refer to the consolidated operations of Evolv Technologies Holdings, Inc. and its subsidiaries. References to “NHIC” refer to the company prior to the consummation of the Merger and references to “Legacy Evolv” refer to Evolv Technologies, Inc. dba Evolv Technology, Inc. prior to the consummation of the Merger.

The following information has been adjusted to reflect the restatement of our condensed consolidated financial statements as described in the "Explanatory Note" at the beginning of this Quarterly Report on Form 10-Q/A and in Note 1 to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q/A.

Business Overview

We are a leader in AI-based weapons detection for security screening. Unlike conventional walk-through metal detectors, our products use advanced sensors, artificial intelligence software, and cloud services to reliably detect guns, improvised explosives, and large knives while ignoring harmless items like phones and keys. This not only enhances security at venues and facilities but also improves the visitor experience by making screening up to ten times faster than alternatives at up to 70% lower total cost.

Our products have screened over 750 million visitors worldwide since our inception. We believe that we have screened more people through advanced systems than any organization other than the United States Transportation Security Administration (“TSA”). Our customers include many iconic venues across a wide variety of industries, including major sports stadiums and arenas, notable performing arts and entertainment venues, major tourist destinations and cultural attractions, hospitals, large industrial workplaces, schools, and prominent houses of worship. We offer our products for lease or purchase and utilize a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities.

Since our inception, we have incurred significant operating losses. Our ability to generate revenue and achieve cost improvements sufficient to achieve profitability will depend on the successful further development and commercialization of our products. We generated revenue of $19.8 million and $9.1 million for the three months ended June 30, 2023 and 2022, respectively. We generated a net loss of $66.8 million and $25.7 million for the three months ended June 30, 2023 and 2022, respectively. We expect to continue to incur operating losses as we focus on growing and establishing recurring commercial sales of our products, including growing our sales and marketing teams, scaling our manufacturing operations, and continuing research and development efforts to develop new products and further enhance our existing products.

Table of Contents

Because of the numerous risks and uncertainties associated with product development and commercialization, we are unable to accurately predict the timing or amount of increased expenses or when, or if, we will be able to achieve or maintain profitability. Until such time, if ever, as we can generate substantial revenue sufficient to achieve profitability, we expect to finance our operations through cash generated from operations, and if necessary, debt financings. However, we may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we are unable to raise capital or enter into such agreements as, and when, needed, we may have to significantly delay, scale back or discontinue the further development and commercialization efforts of one or more of our products, or may be forced to reduce or terminate our operations. See “Liquidity and Capital Resources.”

Key Factors Affecting Our Operating Results

We believe that our performance and future success depend on many factors that present significant opportunities for us but also pose risks and challenges, including those discussed below and in the "Risk Factors" section of our 2022 Form 10-K.

General Economic and Market Conditions

We expect that our results of operations, including our revenue and cost of revenue, may fluctuate or continue to fluctuate based on, among other things, the impact of rising inflation and interest rates on business spending; supply chain issues and the impacts on our manufacturing capabilities; public health emergencies; the ongoing Russian invasion of Ukraine and related geopolitical impacts; and a possible prolonged economic recession. While these factors continue to evolve, we plan to remain flexible and to optimize our business as appropriate and allocate resources, as necessary.

Adoption of our Security Screening Products

We believe the world will continue to focus on the safety and security of people in the places where they gather. Many of these locations, such as professional sports venues, educational institutions, and healthcare facilities, are moving toward a more frictionless security screening experience. We believe that we are well-positioned to take advantage of this opportunity due to our proprietary technologies and distribution capabilities. Our products are designed to empower venues and facilities to realize the full benefits of touchless security screening, including faster visitor throughput, reduced security staff requirements, and a less invasive screening experience for visitors. We expect that our results of operations, including revenue